# Product Learning: Why We Are Doing This

**Document Class:** Aspirational (learning rationale and continuous-improvement context)

**Service Baseline:** 2.1.1

**Last Updated:** 2026-05-29

**Normative Source Note:** Runtime behavior and compatibility guarantees are
normatively defined by `README.md`, `src/`, `tests/`, and `contracts/vitals/`.

## Context
The vitals publisher is a critical component in providing deterministic synthetic vitals and a broker for downstream services. However, gaps in clinical realism validation, outcome reporting, and discovery traceability have been identified. Addressing these gaps is essential to ensure the product's reliability, clinical relevance, and stakeholder trust.

## Why These Exercises Are Important

### 1. Validation and Evidence-Based Decision Making
- **Purpose**: To ensure that clinical realism is not just described but evidenced with repeatable validation records.
- **Outcome**: Builds confidence in the product's ability to simulate real-world clinical scenarios accurately.

### 2. Outcome-Driven Metrics
- **Purpose**: To shift from static KPI targets to trend-based reporting, providing actionable insights over time.
- **Outcome**: Enables the team to measure and improve the product's performance in real-world conditions.

### 3. Traceability and Transparency
- **Purpose**: To standardize discovery logs for scenario and modeling changes, ensuring all assumptions are documented.
- **Outcome**: Improves accountability and facilitates better decision-making by making changes traceable.

### 4. Continuous Improvement
- **Purpose**: To create a feedback loop through validation results and outcome metrics.
- **Outcome**: Ensures the product evolves based on data and stakeholder feedback, maintaining its relevance and reliability.

### 5. Stakeholder Alignment
- **Purpose**: To align clinical reviewers, engineers, and product managers on validation criteria and outcomes.
- **Outcome**: Ensures that all stakeholders are working towards shared goals, reducing miscommunication and inefficiencies.

### 6. Risk Mitigation
- **Purpose**: To reduce the risk of downstream failures and ensure compliance with clinical and technical standards.
- **Outcome**: Proactively addresses potential issues, minimizing disruptions and ensuring product reliability.

## Alignment with Product Management Framework
These exercises align with key principles of the product management framework:
- **Validation**: Testing assumptions against real-world scenarios.
- **Outcome-Oriented Roadmapping**: Focusing on delivering measurable value.
- **Transparency and Accountability**: Ensuring visibility into decision-making processes.
- **Continuous Improvement**: Iteratively refining the product based on data.
- **Stakeholder Collaboration**: Aligning all parties on shared goals.
- **Risk Management**: Proactively identifying and addressing potential issues.

## Documentation Updates
To support these efforts, the following documentation has been added:
- **PRD**: Updated with an "Evidence of Learning" section linking to validation and evidence documentation.
- **ADR**: Architectural decisions documented to reflect the rationale behind these changes.
- **Product Evidence**: Outcome metrics and discovery logs standardized for better traceability.
- **Validation**: Protocols and templates created to ensure repeatable and measurable validation processes.

## Conclusion
By addressing these gaps, the vitals publisher will become a more reliable, clinically relevant, and stakeholder-aligned product. These efforts ensure that the product not only meets current needs but is also prepared to evolve with future requirements.